What Is Brain Stimulation Therapy? TMS, ECT, and VNS Explained
An evidence-based guide to brain stimulation therapies — TMS, ECT, and VNS — including how each works, what to expect, and who they are designed for.
When Medication and Talk Therapy Are Not Enough
For most people, depression, OCD, and other serious mental health conditions respond to a combination of psychotherapy and medication. But for an estimated one in three people with major depression, standard treatments provide inadequate relief — a condition clinicians call treatment-resistant depression.
Brain stimulation therapies exist for exactly this situation. They are not experimental fringes of medicine. Several have been used clinically for decades, endorsed by the National Institute of Mental Health (NIMH), and recommended in clinical guidelines from the American Psychiatric Association (APA) and the World Health Organization (WHO).
This guide explains how the three most established forms — Transcranial Magnetic Stimulation (TMS), Electroconvulsive Therapy (ECT), and Vagus Nerve Stimulation (VNS) — work, who they are for, and what the evidence shows.
What Brain Stimulation Therapy Actually Means
Brain stimulation therapy is an umbrella term for treatments that use electrical, magnetic, or electrical-via-implant energy to directly change brain activity. Unlike psychotherapy, which works through conversation, or medication, which works through chemistry, these approaches modulate the electrical signaling of neurons directly.
They are used when:
- Two or more adequate medication trials have not produced remission
- Side effects from medication are intolerable
- Speed of response is critical (ECT, for example, can work faster than antidepressants)
- A person prefers a non-pharmacological approach for certain conditions
1 in 3
Transcranial Magnetic Stimulation (TMS)
How TMS Works
TMS uses brief, powerful magnetic pulses — similar in strength to those used in MRI machines — delivered through a coil placed against the scalp. The pulses pass painlessly through the skull and stimulate neurons in a targeted brain region, most commonly the left dorsolateral prefrontal cortex, an area consistently underactive in depression.
Stimulating this region repeatedly over a course of treatment appears to strengthen neural pathways associated with mood regulation. Think of it as physical therapy for the brain: targeted, repetitive stimulation that retrains circuitry.
What a TMS Session Looks Like
A standard TMS course involves daily sessions, five days per week, for four to six weeks. Each session lasts 20 to 40 minutes depending on the protocol used. During the session:
- You sit in a reclining chair — no sedation, no anesthesia
- The technician places the TMS coil against your scalp
- You hear clicking sounds and feel a tapping sensation on your head
- You remain awake and alert throughout; many people read or watch television between pulses
- You drive yourself home afterward
Newer accelerated protocols (sometimes called Theta Burst Stimulation or iTBS) compress the same treatment into three-minute sessions or into an intensive schedule completed in days rather than weeks — a format showing strong results in clinical trials.
Who TMS Is For
The FDA has approved TMS for:
- Major depressive disorder that has not responded to at least one antidepressant
- OCD (a specific coil placement targets the supplementary motor area)
- Migraine prevention (a different device)
Research is also exploring TMS for PTSD, anxiety disorders, bipolar disorder, and smoking cessation, but these applications are not yet FDA-approved.
What the Evidence Shows
A landmark NIMH-funded study — the Optimization of TMS for Depression (OPT-TMS) trial — found that 58 percent of participants who had not responded to medication experienced meaningful symptom reduction with TMS, and 37 percent achieved full remission. Multiple meta-analyses confirm these findings, with large effect sizes for depression across diverse populations.
Electroconvulsive Therapy (ECT)
Addressing the Stigma First
ECT carries more stigma than almost any medical procedure — shaped by decades of film and cultural portrayals that bear little resemblance to modern practice. Contemporary ECT is administered under general anesthesia, with muscle relaxants that prevent physical convulsions. The visual drama of older depictions simply does not happen.
The clinical reality is that ECT is often the most effective treatment for severe depression available — and the fastest. For people who are acutely suicidal, who cannot eat or care for themselves, or who have had multiple failed medication trials, ECT can produce life-saving results in days rather than weeks.
How ECT Works
During an ECT session, a brief electrical current is passed through electrodes placed on the scalp to intentionally induce a therapeutic seizure in the brain — lasting typically 20 to 60 seconds. The seizure is not visible from the outside because muscle relaxants have been given. The full procedure takes about 15 to 20 minutes including preparation.
ECT typically involves a course of 6 to 12 sessions, given two to three times per week. Maintenance ECT — monthly sessions to prevent relapse — is often recommended afterward for people with severe recurrent depression.
Who ECT Is For
ECT is generally considered when:
- Depression is severe, life-threatening, or involves psychotic features
- Two or more medication trials have failed
- The person has previously responded well to ECT
- Speed of treatment response is urgent (active suicidal crisis, catatonia, inability to eat)
- The person is pregnant and cannot safely take antidepressants
ECT is also FDA-cleared for bipolar disorder and certain presentations of schizophrenia.
What the Evidence Shows
ECT has the strongest evidence base of any antidepressant treatment. Response rates of 60 to 80 percent are consistently reported in major studies — higher than any single medication. A large 2023 randomized controlled trial published in The New England Journal of Medicine confirmed that ECT outperformed pharmacotherapy for treatment-resistant depression in both response rate and speed of improvement.
60–80%
The main limitation is cognitive side effects: temporary confusion and memory difficulties, particularly around the time of treatment. Most people recover normal memory function over weeks, but some experience longer-lasting gaps for events immediately surrounding treatment. Unilateral electrode placement (one side of the head) significantly reduces cognitive side effects compared to bilateral placement.
Vagus Nerve Stimulation (VNS)
How VNS Works
VNS uses a surgically implanted device — similar to a cardiac pacemaker — that sends mild electrical pulses to the brain via the vagus nerve, the longest cranial nerve, which runs from the brainstem through the chest and abdomen. The device is placed under the skin in the chest during a brief outpatient surgery.
Unlike TMS or ECT, VNS provides continuous stimulation over years. The device activates for about 30 seconds every five minutes, around the clock, modulating mood-regulating circuits over the long term.
Who VNS Is For
The FDA approved VNS for treatment-resistant depression in 2005 — for adults with major depression who have not responded to at least four adequate antidepressant trials. In 2022, the FDA cleared a transcutaneous (external, non-implanted) VNS device specifically for depression, which is worn like a neck collar and requires no surgery.
VNS is considered for:
- Long-standing, severe treatment-resistant depression
- People who cannot tolerate ECT or for whom it has not provided lasting relief
- People willing to commit to a long-term treatment approach
What the Evidence Shows
VNS works slowly. Most people do not see significant improvement for three to six months, and response continues to build over one to two years. This timeline makes it unsuitable for acute crises but potentially valuable for long-term management. A pivotal five-year follow-up study found that 67 percent of VNS patients with treatment-resistant depression achieved meaningful response — a finding that significantly outperforms medication management over the same period.
Comparing the Three Approaches
| TMS | ECT | VNS | |
|---|---|---|---|
| Session setting | Outpatient clinic | Hospital or clinic | Outpatient (surgery), then automatic |
| Anesthesia needed | No | Yes | Surgery only |
| Typical course | 4–6 weeks | 2–4 weeks | Years of continuous use |
| Speed of response | 2–4 weeks | Days to 2 weeks | 3–12 months |
| Best suited for | Moderate treatment-resistant depression, OCD | Severe, urgent, or psychotic depression | Long-term refractory depression |
| FDA-approved for | Depression, OCD | Depression, bipolar, some psychosis | Treatment-resistant depression |
How to Access Brain Stimulation Therapy
Step 1: Talk to your psychiatrist. If you have tried multiple medications without adequate relief, ask directly whether brain stimulation therapy is worth exploring for your situation.
Step 2: Get a referral. TMS is increasingly available at outpatient psychiatric practices and specialty TMS clinics. ECT and VNS are typically offered at academic medical centers or hospital-based psychiatric programs.
Step 3: Ask about insurance. TMS for treatment-resistant depression is broadly covered. ECT is covered in most cases given medical necessity. VNS implant coverage is more variable; the non-implanted transcutaneous device has different coverage rules.
Step 4: Consider psychotherapy alongside these treatments. Combining brain stimulation therapy with evidence-based therapies like CBT tends to produce better long-term outcomes than either alone.
Each form has a different safety profile. TMS is generally well-tolerated — the most common side effects are scalp discomfort and headache; rare but serious risks include seizures (occurring in less than 1 in 1,000 people). ECT carries risks associated with general anesthesia and commonly causes temporary memory disruption, but serious medical complications are rare. VNS surgery carries standard surgical risks; the device itself is well-tolerated, with the most common side effect being voice hoarseness during stimulation pulses. All three are used in medically supervised settings and have established safety records across decades of use.
TMS is generally not described as painful, though many people notice a tapping or knocking sensation on their scalp during pulse delivery. Mild headache is common in the first week or two of treatment and typically diminishes as the course continues. Rarely, a person may find the sensation uncomfortable enough to discontinue, but most people tolerate it well and drive themselves home after each session.
Temporary memory disruption is the most common significant side effect of ECT. Most people experience some confusion and short-term memory difficulty around the time of treatment. Most of this resolves over the weeks following a treatment course. Some people do report gaps in memory for events from the weeks surrounding ECT — memories that may not fully return. Using unilateral (one-sided) electrode placement and the lowest effective dose significantly reduces cognitive side effects. For many people, the severity of untreated depression carries its own cognitive costs, and they report that their overall cognitive functioning improves once depression is lifted.
TMS and neurofeedback both involve the brain, but they work very differently. TMS directly stimulates brain tissue with magnetic pulses — it changes brain activity without your active participation. Neurofeedback trains you to regulate your own brain activity through real-time feedback, relying on your brain's own learning processes. TMS has stronger clinical evidence and FDA approval for depression and OCD; neurofeedback has good evidence for ADHD but more limited evidence for other conditions.
Yes, and it often is. Most people who receive TMS or ECT continue taking their psychiatric medications, and many continue psychotherapy. These treatments are not typically used as isolated replacements for all other care — they are added when those other approaches have been insufficient. Some people ultimately reduce or discontinue medication after achieving remission through brain stimulation, but this happens gradually under medical supervision.
The FDA indication for TMS is adults with major depressive disorder who have had an inadequate response to at least one antidepressant medication at an adequate dose and duration. Most insurance plans follow similar criteria. Your psychiatrist can evaluate whether TMS is clinically appropriate for your situation and help document the prior medication trials needed for insurance authorization. People with implanted metal in or near the head (cochlear implants, some types of aneurysm clips) are generally not candidates for TMS.
TMS is available at many psychiatric practices, hospital outpatient programs, and dedicated TMS clinics. The Clinical TMS Society maintains a provider directory. ECT is typically offered at psychiatric hospitals and academic medical centers. Your psychiatrist is the best starting point — they can refer you to a specialty program and help coordinate care between your ongoing treatment and the brain stimulation procedure.
Exploring Your Treatment Options?
Brain stimulation therapies are one piece of a larger landscape. Understanding all your options — from therapy modalities to advanced treatments — puts you in a stronger position to make an informed decision with your care team.
Explore All Treatment Options